152 related articles for article (PubMed ID: 5586804)
1. [Effect of monoamine oxidase inhibitors on the tryptamine content of the rat brain and on "tryptamine convulsions"].
Popov N; Lietz W; Matthies H
Acta Biol Med Ger; 1967; 18(2):233-44. PubMed ID: 5586804
[No Abstract] [Full Text] [Related]
2. [Effect of dihydroxyphenylalanine on the serotonin content of rat brain following pretreatment with monoamine oxidase inhibitors].
Popov N; Matthies H
Acta Biol Med Ger; 1966; 17(5):637-43. PubMed ID: 5991588
[No Abstract] [Full Text] [Related]
3. [The effect of monoamine oxidase inhibitors and reserpine on the gamma-aminobutyric acid content of the rat brain].
Popov N; Matthies HJ
Acta Biol Med Ger; 1967; 18(1):91-8. PubMed ID: 5587220
[No Abstract] [Full Text] [Related]
4. Comparison of five clinically used inhibitors of monoamine oxidase using the fluorescence microscopy method.
Bartonícek V
Med Pharmacol Exp Int J Exp Med; 1967; 16(2):142-6. PubMed ID: 5298397
[No Abstract] [Full Text] [Related]
5. Relative activity of some inhibitors of mono-amine oxidase in potentiating the action of tryptamine in vitro and in vivo.
MAXWELL DR; GRAY WR; TAYLOR EM
Br J Pharmacol Chemother; 1961 Dec; 17(3):310-20. PubMed ID: 14471627
[TBL] [Abstract][Full Text] [Related]
6. Effect of drugs on the tryptamine content of rat tissues.
Saavedra JM; Axelrod J
J Pharmacol Exp Ther; 1973 Jun; 185(3):523-9. PubMed ID: 4268231
[No Abstract] [Full Text] [Related]
7. Effect of pretreatment with monoamine oxidase inhibitors or (+)-amphetamine on leptazol convulsions in mice and rats.
Turner TA; Spencer PS
J Pharm Pharmacol; 1968 Dec; 20():Suppl:122S+. PubMed ID: 4388144
[No Abstract] [Full Text] [Related]
8. Role of tryptamine in the behavioural changes caused by a monoamine oxidase inhibitor and L-tryptophan [proceedings].
Curzon G; Marsden CA
Br J Pharmacol; 1977 Jun; 60(2):307P-308P. PubMed ID: 880472
[No Abstract] [Full Text] [Related]
9. [The importance of the chemical structure of monoamine oxidase inhibitors for their effect on the gamma-aminobutyric acid content of the rat brain].
Matthies H; Popov N
Acta Biol Med Ger; 1967; 18(5):617-24. PubMed ID: 5589667
[No Abstract] [Full Text] [Related]
10. [Effect of various monoamine oxidase inhibitors on the structure of the sleep-wakefulness cycle of the cat].
Oniani TN; Akhvlediani GR
Fiziol Zh SSSR Im I M Sechenova; 1987 Mar; 73(3):332-7. PubMed ID: 3582693
[TBL] [Abstract][Full Text] [Related]
11. [The modification of the effect of phenelzine, phenylpropylhydrazine and aminooxyacetic acid on the content of gamma-aminobutyric acid in the rat brain by monoamine oxidase inhibitors].
Matthies H; Popov N
Acta Biol Med Ger; 1968; 20(3):371-8. PubMed ID: 5725428
[No Abstract] [Full Text] [Related]
12. Relationship between the pharmacological and biochemical properties of a monoamine oxidase inhibitor preferentially affecting 5-hydroxytryptamine oxidation.
Christmas AJ; Hall DW; Hayward A; Maxwell DR
Br J Pharmacol; 1970 May; 39(1):207P-208P. PubMed ID: 5420104
[No Abstract] [Full Text] [Related]
13. [Excitormotor effects of tryptamine, in presence of IMAO, in mice pretreated with enzymatic inducers].
Denys A; Levy J; Michel-Ber E
Therapie; 1969; 24(5):907-22. PubMed ID: 4391432
[No Abstract] [Full Text] [Related]
14. Effect of psychoactive drugs on in vivo metabolism of 14C-histamine in mouse brain.
Schayer RW; Reilly MA
Arch Int Pharmacodyn Ther; 1973 May; 203(1):123-9. PubMed ID: 4725329
[No Abstract] [Full Text] [Related]
15. [Various effects of monoamine oxidase inhibitors under conditions of complete monoamine oxidase inhibition on the serotonin, dopamine and noradrenaline levels in the rat brain].
Matthies H; Popov N
Acta Biol Med Ger; 1966; 17(4):488-97. PubMed ID: 5983631
[No Abstract] [Full Text] [Related]
16. [Effect of monoamine oxidase inhibitors on the content of catecholamines in different parts of the brain in cats].
Vysotskaia NB; Kaverina NV; Mirzoian RS; Rozonov IuB
Farmakol Toksikol; 1967; 30(3):289-92. PubMed ID: 5597732
[No Abstract] [Full Text] [Related]
17. 2-SUBSTITUTED CYCLOPROPYLAMINES. II. EFFECT OF STRUCTURE UPON MONOAMINE OXIDASE-INHIBITORY ACTIVITY AS MEASURED IN VIVO BY POTENTIATION OF TRYPTAMINE CONVULSIONS.
ZIRKLE CL; KAISER C; TEDESCHI DH; TEDESCHI RE; BURGER A
J Med Pharm Chem; 1962 Nov; 5():1265-84. PubMed ID: 14056459
[No Abstract] [Full Text] [Related]
18. The effects of monoamine oxidase inhibitors on hypothermia produced in rats and rabbits by anaesthetics.
Baird J; Lang WJ
Eur J Pharmacol; 1973 Apr; 22(1):1-9. PubMed ID: 4706878
[No Abstract] [Full Text] [Related]
19. Do monoamine oxidase inhibitors alter carbamazepine blood levels?
Barklage NE; Jefferson JW; Margolis D
J Clin Psychiatry; 1992 Jul; 53(7):258. PubMed ID: 1639748
[No Abstract] [Full Text] [Related]
20. Monoamine oxidase inhibitors, combined with thymoleptics: Are they really unusable for human beings?
Bartonícek VJ
Pharmacology; 1970; 4(2):80-90. PubMed ID: 5528371
[No Abstract] [Full Text] [Related]
[Next] [New Search]
